NovoCure (NVCR) Other Non-Current Liabilities (2014 - 2025)
NovoCure (NVCR) posted Other Non-Current Liabilities of $19000.0 for Q3 2025, up 5.56% sequentially from $18000.0 in Q2 2025, and up 5.56% YoY from $18000.0 in Q3 2024.
NovoCure (NVCR) Other Non-Current Liabilities (2014 - 2025) Analysis & Trends
NovoCure has reported Other Non-Current Liabilities for 12 years, with the latest figure at $19000.0 in Q3 2025.
- Quarterly Other Non-Current Liabilities rose 5.56% year-over-year to $19000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19000.0 (up 5.56% YoY) and the FY2024 annual result came in at $18000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities advanced to $19000.0 in Q3 2025 per NVCR's latest filing, from $18000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $379000.0 in Q3 2021 and troughed at $18000.0 in Q4 2023.
- A 5-year average of $112368.4 and a median of $119000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2023: Other Non-Current Liabilities jumped 125.6% in 2021, then tumbled 87.84% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $166000.0 in 2021, then fell by 10.84% to $148000.0 in 2022, then sank by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then rose by 5.56% to $19000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $19000.0, $18000.0, and $18000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 136,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 379,000.00 |
| Jun 30, 2021 | 173,000.00 |
| Mar 31, 2021 | 177,000.00 |
| Dec 31, 2020 | 337,000.00 |